Erratum
Following publication of this work [1] the authors noticed a mistake within the article’s competing interests section. The correct competing interests section is provided below.
Footnotes
The online version of the original article can be found under doi:10.1186/s12885-016-2159-7.
Competing interests
The authors declare that they have no competing interests. This study is supported by the grant for the Clinical Research of Tokyo Metropolitan Hospital and Taiho Pharmaceutical Inc. who analyzed the thymidine synthase, thymidine phosphorylase, orotate phosphoribosyltransferase, and dihydropyrimidine dehydrogenase using RT-PCR.
Reference
- 1.Okuma Y, Hosomi Y, Miyamoto S, Shibuya M, Okamura T, Hishima T. Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. BMC Cancer. 2016;16:156. doi: 10.1186/s12885-016-2159-7. [DOI] [PMC free article] [PubMed] [Google Scholar]